Skip to main content
Myriad is a machine-readable map of biotech and pharmaceutical work: 100 domains, 1,000 workstreams and 10,000 atomic task nodes that agents can search and route to. It is a taxonomy, not a set of validated protocols: three nodes are implemented as complete skills.

Maturity

The three seed skills are diploid PacBio HiFi assembly optimization, variant-aware CRISPR off-target scoring, and HTS normalization, plate QC and hit calling.
Myriad does not authorize autonomous wet-lab execution, clinical decisions, GMP disposition, regulatory determinations or safety overrides. Operational use requires current primary sources, validated local procedures, appropriate authorization and qualified human review.

Coverage

Molecular and omics, structure and discovery, therapeutics and development, and manufacturing and translation: from genome assembly and single-cell transcriptomics through docking, ADME and CRISPR editing to bioreactor control, clinical trials, pharmacovigilance and GxP.

CLI

Add --json to stats, list, show and validate for machine-readable output.

Design principles

  • Precise routing: task names say when a node should activate and what decision artifact it produces.
  • Progressive disclosure: agents start at the global index, narrow to a domain or workstream, and load a full node only when needed.
  • Evidence before confidence: a score or model output is never treated as experimental, clinical or regulatory proof.
  • Fail closed: nodes support pass, warning, fail and no-call outcomes.
Explore the graph in the browser at myriad-explorer.vercel.app. Code is Apache-2.0 and content CC BY 4.0. Source: KalarisLabs/Myriad.
Last modified on November 15, 2026